Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide

Inhibition of protein deacetylation enzymes, alone or in combination with standard chemotherapies, is an exciting addition to cancer therapy. We have investigated the effect of deacetylase inhibition on the metabolism of glioblastoma cells. 1H NMR metabolomics analysis was used to determine the majo...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Miroslava Cuperlovic-Culf, Mohamed Touaibia, Patrick-Denis St-Coeur, Julie Poitras, Pier Morin, Adrian S. Culf
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2014-09-01
Serie:	Metabolites
Soggetti:	metaboloepigenomics NMR metabolomics glioblastoma enzyme inhibitors combined treatment
Accesso online:	http://www.mdpi.com/2218-1989/4/3/807
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!